Exhale

The official blog of the Lung Institute.

Top 4 Things People Don’t Know about Cellular Therapy for Lung Disease

19 Nov 2013
| Under Press | Posted by
| 0 Comments

Lung Institute Supports COPD Awareness Month by Educating Public on Innovative Pulmonary Treatment Options

Tampa, Fla. (November 19, 2013) – In support of chronic obstructive pulmonary disease (COPD) Awareness Month and the US COPD Coalition, the Lung Institute is informing people about innovative treatment options for lung disease. Once considered an alternative form of treatment for lung disease, cellular therapys have taken center stage as a viable option for people with chronic pulmonary diseases. To dispel any controversy or misunderstanding about the subject of cellular therapys, the Lung Institute offers the following four true and false facts for people to learn more about cellular therapys.

Top 5 Things People Don’t Know about Cellular Treatments for Lung Disease

  • T or F: Individuals with COPD don’t have many treatment options. FALSE. Although COPD is a progressive disorder, people have many types of treatment options, including the promising option of cellular therapy.
  • T or F: Cellular therapy procedures are always invasive and painful. FALSE. Many types of cellular procedures, are minimally invasive.
  • T or F: Cellular therapy has been known to improve quality of life for people with many types of chronic lung diseases. TRUE. Cellular therapy has been known to improve the quality of life of patients suffering from many types of chronic lung diseases.
  • T or F: There is a risk of rejection by the body with cellular therapy. FALSE. Since the cells are derived from the patient’s own body, there is no risk of rejection.

About Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.